Physician profile
Jonmichael Samsel
NPI 1003492653
$3,279.76
in general payments reported to CMS, 2019-2025
19 companies · $854 in 2025
The $854 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $264 · 2023: $557 · 2024: $1,604 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,925 · Education: $89.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,925.46 |
| Education | $89.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,178.30 | 2023-2025 | Rinvoq, Skyrizi |
| Lilly USA, LLC | $307.26 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $240.02 | 2022-2025 | Opzelura |
| Janssen Biotech, INC. | $238.60 | 2023-2025 | Tremfya |
| Ucb, INC. | $235.24 | 2023-2025 | Bimzelx |
| Amgen INC. | $212.23 | 2022-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $143.26 | 2022-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $89.95 | 2024 | |
| Genzyme Corporation | $87.31 | 2024-2025 | |
| Galderma Laboratories, L.P. | $87.27 | 2024-2025 | Nemluvio, Aklief |
| Sun Pharmaceutical Industries INC. | $78.51 | 2022-2023 | Ilumya, Winlevi |
| Leo Pharma INC. | $71.30 | 2023-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $66.16 | 2024-2025 | Zoryve |
| Pfizer INC. | $60.57 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.92 | 2023-2024 | Spevigo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $56.24 | 2025 | Purified Cortrophin Gel |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.26 | 2022 | |
| Organogenesis INC. | $25.55 | 2024 | |
| Kerecis Limited | $13.81 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonmichael Samsel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.